secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001823239-23-000041
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences shareholders elect three Class III directors at 2023 annual meeting
--------------------------------------------------------------------------------

- Anat Ashkenazi, Gregory T. Lucier, and Luke Marker elected as Class III directors with over 183M votes each.
- Ratification of Ernst & Young as independent auditor for 2023 passed with 234,840,684 votes for, 15,103 against.
- Non-binding advisory vote on executive compensation approved: 221,869,456 for, 8,907,696 against.
- Quorum present: 234,865,441 of 250,882,769 outstanding shares, representing approximately 93.6%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/0001823239-23-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323923000041/mrvi-20230518.htm
  HTML page:      https://secwatch.observer/filing/0001823239-23-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer